{{Rsnum
|rsid=473224
|Gene=LIPC
|Chromosome=15
|position=58445142
|Orientation=minus
|GMAF=0.09871
|Gene_s=LIPC
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 5.3 | 28.3 | 66.4
| HCB | 0.0 | 5.9 | 94.1
| JPT | 0.9 | 13.4 | 85.7
| YRI | 3.4 | 19.2 | 77.4
| ASW | 7.0 | 19.3 | 73.7
| CHB | 0.0 | 5.9 | 94.1
| CHD | 0.0 | 3.7 | 96.3
| GIH | 1.0 | 13.9 | 85.1
| LWK | 2.7 | 10.9 | 86.4
| MEX | 3.5 | 17.5 | 78.9
| MKK | 0.6 | 12.9 | 86.5
| TSI | 1.0 | 21.6 | 77.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23262498
|Title=Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy
}}

{{PMID Auto
|PMID=19101670
|Title=LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}